Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, ...

The FDA expands warnings on COVID-19 vaccines regarding myocarditis risk, particularly in young males aged 12 to 24.

The Karnataka government declared 14 drugs manufactured by different companies “substandard” on 25 June 2025, and warned ...

KA Gov Flags 14 Drugs As Sub-Standard directs chemists, wholesalers, doctors, hospitals, and nursing homes not to stock, sell ...

A spate of mid-flight illnesses on a recent Air India London–Mumbai service has cast a harsh light on airline catering ...

Wegovy, a weekly weight-loss injection by Novo Nordisk, has launched in India. Priced from Rs 17,000/month, it helps users lose up to 20 per cent body weight. But is it safe? Experts answer.

The Food and Drug Administration department of the US has updated its warning about rare heart risk associated with to ...

This product, bioequivalent to Motegrity Tablets of Takeda Pharmaceuticals, will be manufactured at Lupin's Goa facility in ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for prucalopride ...

A recent analysis of U.S. pharmacy claims reveals that nearly two-thirds of patients who initiated Wegovy or Zepbound in ...

Robert F. Kennedy Jr., the U.S. Health Secretary, dismissed all members of the national vaccine advisory board. He appointed ...

The Karnataka government’s Drug Testing Laboratory declared 14 drugs manufactured by 14 different companies as “substandard” on Wednesday. The state’s Food Safety and Drug Administration department ...